Johanna Mercier, President and Head, U.S. Commercial, Bristol-Myers Squibb
Christine Brown, Associate Research Professor, City of Hope
Mark Lowdell, Director of Cellular Therapy, UCL, CSO and Founder, InMuneBio
Karin Jooss, Executive Vice President of Research, Chief Scientific Officer, Gritstone Oncology
Keith Knutson, Director, Cancer Vaccine & Immune Therapies Program, Mayo Clinic
Michael DeRidder, Head of Commercial Strategy, Oncology Cell Therapy, GSK
Fred Ramsdell, SVP, Research, Fred Parker Institute
Bahram Valamehr, Vice President, Cancer Immunotherapy and Reprogramming Biology, Fate Therapeutics
Hans Klingemann, VP, Research and Development, NantKwest
Mark Poznansky, Director, Vaccine and Immunotherapy Center, Massachusetts General Hospital
It’s not just about the conference sessions, our Congress recognises the importance of networking.
With roundtable discussions, themed networking receptions, networking lunches and our networking app we offer plenty of opportunities to network with your peers and continue conversations in good company.
The World Immunotherapy Congress brings together the pioneers doing the most innovative work within the industry and across the whole value chain, to share their unique insights with you.
The event looks at commercialising and pushing forward the entire developmental pipeline as well as focusing on the hottest new individual therapeutics.
This is the perfect platform to generate new leads, create brand awareness and launch new products. No other marketing gets you in a room with so many potential customers looking for suppliers.
Sponsorship packages are tailored to meet your specific marketing goals. And, the exhibition floor does sell out, so don’t delay.
The agenda was shaped by an industry advisory board, with members including
SVP and Head Global Clinical Development, Chief Medical Officer
Merck, Sharp & Dohme (MSD)
Vice President of Research and Development
Associate Director, Multispecific Biologics Engineering
Janssen Research & Development
Senior Director, Early Pipeline Commercial Strategy for Oncology Cell Therapy
Senior Director and Head, Antibody Discovery
Head of Bio Structure and Biophysics
AbbVie Abzena ADC Therapeutics Alligator Bioscience Amgen AstraZeneca Biogen Biosim Spanish Association of Biosimilars Boehringer Ingelheim Bristol Myers Squibb Cancer Research UK Cinfa Biotech GmbH Dr. Reddy's Laboratories SA. Duke University Medical Centre Eli Lilly & Co European Molecular Biology Laboratory European Patent Office European Specialist Nurses Organisations Ferrer International Fraunhofer IME Gedeon Richter Goldstein & Fox GSK HPAPI Project Services Ltd Janssen Libbs Pharmaceutica Lonza mAbs Macrogenics Maverick Therapeutics MedImmune Merck Merck, Sharp & Dohme (MSD) Napp pharmaceuticals NAPP Pharmaceuticals NBE Therapeutics NHS NIBR NICE NIHR Clinical Research Network (NIHR CRN) Norwegian Medicines Agency Novartis NovImmune NxR Biotechnologies Opsona Therapeutics Oril Industrie Ossianix PAREXEL Paul Ehrlich Institute Pfizer Biotherapeutics Pieris Pharmaceuticals Pierre Fabre Prima BioMed Roche Roche S.A.Toral SafeBridge Sandoz Biopharmaceuticals Sandoz Sanofi Sanofi R&D Sanquin Seattle Genetics Technische Universität Braunschweig Teva Pharmaceuticals The Royal Marsden NHS Foundation Trust Therapeomic TU Wien UCB Celltech University of Cambridge University of Denmark University of Messina – Italy University of Stuttgart
Make sure you are at the forefront of the big pharma and biotech industry. No matter where your interest lies, at the Americas Antibody Congress, World Immunotherapy Congress USA and World Biosimilar Congress USA, we have content, networking and potential partners for you.
Download the brochure to find out exactly what's in store for this year's event.